A total of 74 new medications have been added to China's national medical insurance catalog, with prices of 67 medicine types slashed by an average of 61.71 percent, the National Healthcare Security Administration (NHSA) said on Friday.
Seven drugs for rare diseases, medicines for tumors, chronic diseases, anti-infection treatment, and those specifically for women or children are among the additions to the reimbursement list.
Eleven medications with low clinical value and low demand have been removed from the list, noted the NHSA.
"All the exclusions have their alternatives with equivalent or better efficaciousness in the catalog," said Huang Huabo with the NHSA, adding that the withdrawal will enable more new, quality drugs to be listed.
A total of 507 medications have been added to the list since the inauguration of the NHSA in 2018, bringing the list to 2,860 items. The updated catalog will go into effect on Jan. 1, 2022.